Background: Twin pregnancies are found to be associated with greater risks to the mother and the babies. The normal length of gestation for an average pregnancy is around 40 weeks however in multiple pregnancies (twins, triplets, quadruplets, etc) it is usually shorter. Methods: A prospective observational study of women with twin pregnancy was carried out in a tertiary care hospital, in Maharashtra, from October 2020 to October 2022 with the purpose to assess the maternal and neonatal outcomes. 100 women with twin pregnancies who were registered to the hospital were selected for the study as per the inclusion and exclusion criteria. Results: 64% of women with twin pregnancies were in the age group of 21-30 years. Most of them had pregnancy as a result of the spontaneous type of conception. It was found that the vaginally delivered twins (20%) were at gestational age above 37 weeks and 8% at less than 32 weeks. 38% of twins were delivered by LSCS (elective LSCS 6% and emergency LSCS 38%). The gestational age at the time of delivery was found as 35-37 weeks (Mean ±SD 36 ± 1.2). 46% of neonates were shifted to NICU. The incidence of low birth weight and respiratory distress was more in babies born at 37 weeks and below. It was also observed that the as gestational age increased the perinatal deaths decreased. Conclusions: Regular follow-up of women with twin pregnancies is necessary for attainment of positive outcomes.

Background: Anaemia during pregnancy is considered to be a serious health concern. Whilst oral supplementation is most prevalent, it is also possible to provide iron parentally to replace the deficit. Methods: An observational study was conducted in the department of obstetrics and gynaecology of a tertiary care hospital, in Maharashtra. Total 110 women with iron deficiency anaemia were randomly divided into two groups using computer generated random numbers. Group A received oral iron therapy and group B received intravenous sucrose therapy. The haemoglobin and serum ferritin were assessed before and after treatment. Results: In the oral iron therapy group the age ranged between 19.3 to 27.1 years and in intravenous iron therapy group from 19.2 and 26.5 years. Baseline (0 day) haemoglobin in oral iron therapy group was 8.21±1.12 gm/dl and 8.36±1.14 gm/dl in intravenous iron group. The mean difference of 3.38 gm/dl was seen in the intravenous therapy group at 8th weeks against the mean difference of 1.63 gm/dl in oral iron therapy group. The mean difference of serum ferritin 18.92 µg/l was found in the oral iron therapy at the 8th week while the mean difference of 63.79 µg/l was seen in the intravenous therapy group. Conclusions: The intravenous sucrose therapy is found to be safe and effective alternative treatment for iron deficiency anaemia in pregnancy though the cost of treatment is significantly higher than the oral therapy.